Czasopismo
Tytuł artykułu
Autorzy
Warianty tytułu
R&D Expenditures and Market Value of Biotechnology Firms
Języki publikacji
Abstrakty
Celem niniejszej pracy jest określenie wpływu inwestycji w działalność badawczo- rozwojową na wartość rynkową firm biotechnologicznych. Próba badawcza składa się z 52 największych inwestorów B+R z europejskiego sektora biotechnologii. Dane wykorzystane w analizach pochodzą z raportu The UE Industrial R&D Investment Scoreboard. W celu znalezienia odpowiedzi na postawione pytanie badawcze zastosowano metodę regresji liniowej. Wyniki badań wskazują, że istnieje pozytywny związek między inwestycjami firm biotechnologicznych w działalność B+R a ich wartością rynkową(abstrakt oryginalny)
The aim of this article is to determine the influence of investment in R&D activity on market value of biotechnology firms. The research sample includes 52 biggest R&D investors from the European biotechnology sector. The data used in the analyses come from the raport titled The UE Industrial R&D Investment Scoreboard. To answer the research questions linear regression model was used. The research results show that there is a positive relationship between biotechnology firms investment in R&D activity and their market value(original abstract)
Słowa kluczowe
Rocznik
Strony
59--66
Opis fizyczny
Twórcy
autor
- Uniwersytet Przyrodniczy w Lublinie
autor
- Uniwersytet Przyrodniczy w Lublinie
Bibliografia
- Aiken L.S., West, S.G., 1991, Multiple Regression: Testing and Interpreting Interactions, Sage, Newbury Park.
- Al-Laham A., Tzabbar D., Amburgey T.L., 2011, The dynamics of knowledge stocks and knowledge flows: Innovation consequences of recruitment and collaboration in biotech, Industrial and Corporate Change, vol. 20, no. 2, s. 555-583.
- Barth M.E., Kallapur S., 1996, The effects of cross-sectional scale differences on regressions results in empirical accounting research, Contemporary Accounting Research, vol. 13, s. 527-567.
- Blank S., 2008, Small and Medium Enterprises in Agricultural Biotechnology, www.oecd.org/dataoecd/11/59/40925488.pdf (15.09.2014).
- Callen J. Gavious I., Segal D., 2010, The complementary relationship between financial and non-financial information in the biotechnology industry and the degree of investor sophistication, Journal of Contemporary Accounting & Economics, vol. 6, s. 61-76.
- Enzing C., 2011, Sectoral Innovation Watch. Biotechnology Sector, http://ec.europa.eu/enterprise/policies/innovation/files/proinno/sector-report-biotechnology_en.pdf (15.09.2014).
- Fama E.F., 1991, Efficient capital markets, Journal of Finance, vol. 46, no. 5, s. 1575-1617.
- Griliches Z., 1981, Market value, R&D, and patents, Economic Letters, vol. 7, no. 2, s. 183-187.
- Hall B.H., 2000, Innovation and market value, [w:] Barrell R., Mason G., O'Mahoney M. (eds.), Productivity, Innovation and Economic Performance, Cambridge University Press, Cambridge, s. 177-198.
- Hall B.H., Thoma G., Torrisi S., 2007, The market value of patents and R&D: Evidence from European firms, www.nber.org/papers/w13426 (15.09.2014).
- Hand J.R.M., 2004, The market valuation of biotechnology firms and biotechnology R&D, [w:] McCahery J., Renneboog L. (eds.), Venture Capital Contracting and the Valuation of High-Technology Firms, Oxford University Press, Oxford, s. 251-280.
- Hine D., Kapeleris J., 2006, Innovation and Entrepreneurship in Biotechnology, an International Perspective: Concepts, Theories and Cases, Edward Elgar Publishing, Cheltenham..
- Kijek T., 2014. Market valuation of innovation capital, International Journal of Innovation and Learning, vol. 15, no. 4, s. 411-421.
- Kijek T., Chojnacki P., 2014, R&D expenditures and market value of biotechnology firms, Roczniki Naukowe Stowarzyszenia Ekonomistów Rolnictwa i Agrobiznesu, t. 16, z. 6, s. 77-81.
- OECD 2009: OECD Biotechnology Statistics, Paris.
- Piergiovanni R., Santarelli E., 2013, The more you spend, the more you get? The effects of R&D and capital expenditures on the patenting activities of biotechnology firms, Scientometrics, vol. 94, s. 497-521.
- Pisano G., 2006, Science Business: The Promise, The Reality, and The Future of Biotech, Harvard Business School Press, Boston.
- Shevlin T., 1996, The value-relevance of nonfinancial information: A discussion, Journal of Accounting and Economics, vol. 22, no. 1-3, s. 31-42.
- Xu B., Magnan M., Andre P., 2007, The stock market valuation of R&D information in biotech firms, Contemporary Accounting Research, vol. 24, s. 1291-1318.
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.ekon-element-000171441718